(Q33292143)

25 July 2017

title

Prognostic significance of drug-regulated genes in high-grade osteosarcoma (English)

1 reference

25 July 2017

Joerg Fellenberg

1

1 reference

25 July 2017

Ludger Bernd

2

1 reference

25 July 2017

Guenter Delling

3

1 reference

25 July 2017

Daniela Witte

4

1 reference

25 July 2017

Anita Zahlten-Hinguranage

5

1 reference

25 July 2017

publication date

27 July 2007

1 reference

25 July 2017

1 reference

25 July 2017

volume

20

1 reference

25 July 2017

issue

10

1 reference

25 July 2017

page(s)

1085-1094

1 reference

https://scigraph.springernature.com/pub.10.1038/modpathol.3800937

25 July 2017

exact match

0 references

cites work

Primary Osteosarcoma of Bone: A Clinicopathologic Investigation of 243 Cases, with Necropsy Studies in 54

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800937

7 January 2021

Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800937

7 January 2021

Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800937

7 January 2021

Prognostic significance of serum alkaline phosphatase measurements in patients with osteosarcoma treated with adjuvant or neoadjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800937

7 January 2021

Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800937

7 January 2021

P-glycoprotein expression in osteosarcoma: a basis for risk-adapted adjuvant chemotherapy.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800937

7 January 2021

Tumor size and prognosis in aggressively treated osteosarcoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800937

7 January 2021

Tumor volume change after chemotheraphy as a predictive factor of disease free survival for osteosarcoma.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800937

7 January 2021

Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800937

7 January 2021

Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: osteosarcoma and related tumors

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800937

7 January 2021

Prognostic significance of allelic imbalance at the c-kit gene locus and c-kit overexpression by immunohistochemistry in pediatric osteosarcomas.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800937

7 January 2021

DNA sequence copy number increase at 8q: a potential new prognostic marker in high-grade osteosarcoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800937

7 January 2021

Human osteosarcoma expresses specific ephrin profiles: implications for tumorigenicity and prognosis.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800937

7 January 2021

Correlation of c-fos, p53, and PCNA expression with treatment outcome in osteosarcoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800937

7 January 2021

Expression profiles of osteosarcoma that can predict response to chemotherapy.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800937

7 January 2021

An expression signature classifies chemotherapy-resistant pediatric osteosarcoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800937

7 January 2021

Identification of drug‐regulated genes in osteosarcoma cells

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800937

7 January 2021

Evaluation of the predictive value of Her-2/neu gene expression on osteosarcoma therapy in laser-microdissected paraffin-embedded tissue

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800937

7 January 2021

Inosine monophosphate dehydrogenase expression: transcriptional regulation of the type I and type II genes

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800937

7 January 2021

IMP dehydrogenase inhibitor mycophenolate mofetil induces caspase-dependent apoptosis and cell cycle inhibition in multiple myeloma cells

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800937

7 January 2021

Modulation of IMPDH2, survivin, topoisomerase I and vimentin increases sensitivity to methotrexate in HT29 human colon cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800937

7 January 2021

MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800937

7 January 2021

Non-coding RNAs: hope or hype?

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800937

7 January 2021

An abundance of RNA regulators

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800937

7 January 2021

Rho GTPases are over-expressed in human tumors.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800937

7 January 2021

Overexpression of RhoA mRNA is associated with advanced stage in testicular germ cell tumour

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800937

7 January 2021

Rho/ROCK pathway as a target of tumor therapy

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800937

7 January 2021

RhoA GTPase inactivation by statins induces osteosarcoma cell apoptosis by inhibiting p42/p44-MAPKs-Bcl-2 signaling independently of BMP-2 and cell differentiation

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800937

7 January 2021

Reversal of the malignant phenotype of gastric cancer cells by inhibition of RhoA expression and activity

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800937

7 January 2021

Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800937

7 January 2021

Ferritin contributes to melanoma progression by modulating cell growth and sensitivity to oxidative stress

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800937

7 January 2021

Tissue ferritin concentration and prognosis in carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800937

7 January 2021

Identification of genes down-regulated during melanoma progression: a cDNA array study

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800937

7 January 2021

Surface-enhanced laser desorption/ionization time of flight mass spectrometry protein profiling identifies ubiquitin and ferritin light chain as prognostic biomarkers in node-negative breast cancer tumors

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800937

7 January 2021

Prohibitin is required for Ras-induced Raf-MEK-ERK activation and epithelial cell migration

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800937

7 January 2021

Phosphoinositide binding regulates alpha-actinin dynamics: mechanism for modulating cytoskeletal remodeling.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800937

7 January 2021

Prohibitin: a potential target for new therapeutics

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800937

7 January 2021

10.1038/MODPATHOL.3800937

Identifiers

DOI

1 reference

Dimensions Publication ID

25 July 2017

1020470732

0 references

1 reference